León
Universidad
Netherlands Cancer Institute
Amsterda, HolandaPublicaciones en colaboración con investigadores/as de Netherlands Cancer Institute (9)
2007
-
Involvement of breast cancer resistance protein (ABCG2) in the biliary excretion mechanism of fluoroquinolones
Drug Metabolism and Disposition, Vol. 35, Núm. 10, pp. 1873-1879
-
Multidrug transporter ABCG2/breast cancer resistance protein secretes riboflavin (vitamin B2) into milk
Molecular and Cellular Biology, Vol. 27, Núm. 4, pp. 1247-1253
2006
-
Breast cancer resistance protein (BCRP/ABCG2) transports fluoroquinolone antibiotics and affects their oral availability, pharmacokinetics, and milk secretion
Drug Metabolism and Disposition, Vol. 34, Núm. 4, pp. 690-695
-
Breast cancer resistance protein (Bcrp1/Abcg2) reduces systemic exposure of the dietary carcinogens aflatoxin B1, IQ and Trp-P-1 but also mediates their secretion into breast milk
Carcinogenesis, Vol. 27, Núm. 1, pp. 123-130
2005
-
Human cancer resistance protein: Interactions with steroid drugs, hormones, the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine, and transport of cimetidine
Journal of Pharmacology and Experimental Therapeutics, Vol. 312, Núm. 1, pp. 144-152
-
Sex-dependent expression and activity of the ATP-binding cassette transporter breast cancer resistance protein (BCRP/ABCG2) in liver
Molecular Pharmacology, Vol. 67, Núm. 5, pp. 1765-1771
-
The breast cancer resistance protein (BCRP/ABCG2) affects pharmacokinetics, hepatobiliary excretion, and milk secretion of the antibiotic nitrofurantoin
Molecular Pharmacology, Vol. 67, Núm. 5, pp. 1758-1764
-
The breast cancer resistance protein BCRP (ABCG2) concentrates drugs and carcinogenic xenotoxins into milk
Nature Medicine, Vol. 11, Núm. 2, pp. 127-129
-
Transport of anthelmintic benzimidazole drugs by breast cancer resistance protein (BCRP/ABCG2)
Drug Metabolism and Disposition, Vol. 33, Núm. 5, pp. 614-618